Zurzuvae was generally well-tolerated, with the most common side effects being sedation, somnolence and dizziness.

OlivePoint acquires a Class A Raleigh office 100% leased to PPD/Thermo Fisher, highlighting its strategy to target mispriced, ...

The Life Sciences BPO Market is expanding rapidly, driven by rising R&D costs, increasing regulatory complexities and the growing need for operational efficiency across pharma and biotech sectors.

The global clinical trials market is anticipated to grow at a CAGR of 6-7% from 2024 to 2029. This growth is driven by the ...

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of Gibco(TM) Bacto(TM) CD Supreme FPM Plus and Gibco(TM) Bacto(TM) CD Supreme Feed (2X), two ...

Investors interested in arranging a meeting with company management during the conference should contact the Bank of America conference coordinator. A live audio webcast of the presentation can be ...

With new UK clinical trial rules landing in 2026, the EU Biotech Act on the horizon and China and Australia gaining ground, ...

New formulations simplify microbial bioprocessing, helping innovators scale plasmid DNA and protein production with confidenceWALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world ...

To address this, Thermo Fisher Scientific now offers Accelerator Drug Development: a suite of integrated services combining CDMO and CRO capabilities to streamline the drug development journey, from ...

According to Precedence Research, the global real-world data (RWD)market size will grow from USD 1.88 billion in 2025 to ...

GLP-1 drug could offset metabolic risks of second-generation antipsychotics ...

Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced ...